GlassScriptPhysician profile
Todd A Adelson
NPI 1124088075
$1,170.15
in general payments reported to CMS, 2019-2025
17 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.68 · 2020: $11.36 · 2021: $76.94 · 2022: $416 · 2023: $118 · 2024: $174 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $329.95 | 2019-2025 | Argos, Clareon Panoptix Pro, Clareon |
| Rxsight INC | $164.70 | 2022 | |
| Ocular Therapeutix, INC. | $124.28 | 2023-2025 | Dextenza |
| New World Medical,INC. | $103.08 | 2022-2025 | Streamline, Kahook Dual Blade, Clearpath |
| Oyster Point Pharma, INC. | $71.60 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.18 | 2019-2021 | |
| Dompe US, INC. | $63.92 | 2025 | Oxervate |
| Bausch & Lomb Americas INC. | $41.48 | 2022-2025 | Envista Envy Iol |
| Johnson & Johnson Surgical Vision, INC. | $38.94 | 2024 | Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $36.41 | 2024-2025 | Xdemvy |
| Allergan, INC. | $22.74 | 2021 | |
| Eyevance Pharmaceuticals LLC | $20.19 | 2022 | |
| Abbvie INC. | $19.69 | 2022 | |
| Glaukos Corporation | $19.64 | 2022 | |
| Sight Sciences, INC. | $16.69 | 2023 | Tearcare System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $15.30 | 2021 | |
| Sun Pharmaceutical Industries INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Adelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.